Rigorous research finds positive result on mental health outcomes
The TGA’s decision to approve psychedelics for the treatment of depression and PTSD is a significant milestone for mental health treatment in Australia. It provides hope for those who have been struggling with these conditions and have exhausted all other treatment options. While there are still challenges to overcome, this decision paves the way for further research and the safe and effective use of psychedelics in mental health treatment.
It’s important to note that the TGA’s decision does not mean that psychedelics will be widely available for use in Australia. The approval is only for use in clinical trials and for specialist doctors to prescribe on a case-by-case basis for patients who have exhausted all other treatment options. Strict controls will be put in place to ensure the safe use of these substances, including monitoring for adverse effects.
Funding Futures together with VentureCrowd, To find out more about Conscious Investing head to www.venturecrowd.com.au
